HighTower Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.18M Sell
89,703
-5,314
-6% -$129K ﹤0.01% 1519
2025
Q1
$1.97M Buy
95,017
+51,780
+120% +$1.07M ﹤0.01% 1530
2024
Q4
$1.02M Sell
43,237
-8,472
-16% -$199K ﹤0.01% 1949
2024
Q3
$1.32M Sell
51,709
-27,859
-35% -$710K ﹤0.01% 1758
2024
Q2
$1.87M Sell
79,568
-26,057
-25% -$611K ﹤0.01% 1486
2024
Q1
$3.03M Sell
105,625
-11,814
-10% -$339K ﹤0.01% 1211
2023
Q4
$3.85M Sell
117,439
-13,904
-11% -$456K 0.01% 1097
2023
Q3
$3.65M Sell
131,343
-7,975
-6% -$222K 0.01% 1066
2023
Q2
$4.76M Buy
139,318
+26,535
+24% +$906K 0.01% 926
2023
Q1
$3.4M Buy
112,783
+12,636
+13% +$381K 0.01% 1024
2022
Q4
$2.82M Sell
100,147
-41,580
-29% -$1.17M 0.01% 1090
2022
Q3
$4.65M Sell
141,727
-108,690
-43% -$3.56M 0.01% 832
2022
Q2
$7.87M Buy
250,417
+38,614
+18% +$1.21M 0.02% 649
2022
Q1
$9.72M Buy
211,803
+26,966
+15% +$1.24M 0.02% 638
2021
Q4
$11.3M Sell
184,837
-23,940
-11% -$1.47M 0.02% 555
2021
Q3
$15.6M Buy
208,777
+442
+0.2% +$33K 0.04% 395
2021
Q2
$19.3M Sell
208,335
-18,359
-8% -$1.7M 0.06% 322
2021
Q1
$20.1M Buy
226,694
+56,373
+33% +$5M 0.06% 304
2020
Q4
$15.9M Buy
170,321
+53,762
+46% +$5.01M 0.07% 275
2020
Q3
$7.42M Buy
116,559
+22,634
+24% +$1.44M 0.04% 427
2020
Q2
$4.9M Buy
93,925
+7,570
+9% +$395K 0.03% 519
2020
Q1
$2.7M Buy
86,355
+24,001
+38% +$752K 0.02% 643
2019
Q4
$2.09M Buy
62,354
+2,300
+4% +$77.2K 0.01% 834
2019
Q3
$1.78M Buy
60,054
+2,103
+4% +$62.2K 0.01% 927
2019
Q2
$2M Buy
57,951
+6,239
+12% +$215K 0.01% 902
2019
Q1
$1.7M Sell
51,712
-10,313
-17% -$340K 0.01% 918
2018
Q4
$1.49M Buy
62,025
+19,921
+47% +$478K 0.01% 884
2018
Q3
$1.41M Buy
42,104
+12,608
+43% +$422K 0.01% 980
2018
Q2
$858K Buy
29,496
+9,883
+50% +$287K 0.01% 1193
2018
Q1
$507K Buy
+19,613
New +$507K ﹤0.01% 1406